Future Trends in Synthetic Biology Asia Workshop
Abstract
Synthetic biology continues to advance at a rapid pace. Chinese researchers recently publicized that they are engineering humans in utero. The Chinese government is heavily investing in synthetic biology as a strategic investment. The commercial market has bought into synthetic biology for high-value compounds (e.g., flavors, fragrances, fine chemicals, pharmaceuticals). Companies are already profiting in this sector. These market-driven technologies are enabling the development of relevant applications in other areas. Companies are leveraging their investment in synthetic biology platforms to engineer a variety of biological chassis for production of novel materials, more complex sensors, advanced data storage technology, to name a few. This drive is enabling new ways to create more energetic materials, stronger armor, transparent materials, for example, which will help advance Navy capabilities. The challenge is to identify where investments need to be made with the highest return on investment.
Document Details
- Document Type
- DoD Grant Award
- Publication Date
- May 23, 2019
- Source ID
- N629091912068
Entities
People
- Matthew Chang
Organizations
- National University of Singapore
- Office of Naval Research
- United States Navy